
Location: Torrance, CA | Employment Type: Full-Time
At PolyPeptide, your work directly impacts life-changing medicines. As a Process Development Chemist, you’ll be hands-on in peptide manufacturing, working with advanced synthesis, purification, and drying processes in a collaborative GMP environment. This is an ideal role for a chemist who enjoys precision, ownership, and seeing their work move from lab to customer.
You’ll contribute to high-quality peptide production while building deep technical expertise alongside experienced chemists, all while upholding PolyPeptide’s commitment to safety, quality, and on-time delivery.
PolyPeptide is a global leader in peptide-based active pharmaceutical ingredients, partnering with innovators worldwide to deliver high-quality, reliable solutions. Our teams are driven by science, collaboration, and a shared commitment to excellence.
If you’re ready to grow your chemistry career while making a real impact, we’d love to hear from you.
Salary: $30-$35/hr
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity or expression, pregnancy, age, national origin, disability status, genetic information, protected veteran status, or any other characteristic protected by law.

PolyPeptide Group AG with its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) which specializes in the development and manufacturing of synthetic peptides and oligonucleotides used as active pharmaceutical ingredients (API) or intermediates in therapeutic products. It also produces a range of generic peptides and peptides used in cosmetics. The Group mainly serves pharmaceutical and biotech companies. By supporting its customers, PolyPeptide contributes to the health of millions of patients across the world. PolyPeptide provides its offering from pre-clinical through to commercial stages. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Established in 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.
Find out more about our current vacancies at: https://polypeptide.teamtailor.com/